Difficulty: Medium
Average Score: 66%
Practice
Withdrawal of antiseizure drugs can increase seizure frequency. Which drug has the least withdrawal risk?
Correct answer
C
Rationale
In the context of pharmacology of CNS drugs, the question about withdrawal risk is crucial for understanding the management of patients with seizure disorders. The correct answer is C) Ethosuximide.
Ethosuximide is the least likely to increase seizure frequency upon withdrawal compared to the other options. This is because ethosuximide is primarily used in absence seizures and does not have significant effects on other types of seizures. Therefore, its withdrawal is less likely to lead to rebound seizures.
Clonazepam (Option A) and Diazepam (Option B) are benzodiazepines commonly used for seizure control. Abrupt withdrawal of these drugs can lead to rebound seizures due to their potent antiseizure effects and potential for dependence.
Phenobarbital (Option D) is a barbiturate with a long half-life and potent antiseizure properties. Abrupt discontinuation of phenobarbital can result in a withdrawal syndrome characterized by an increased risk of seizures.
Educationally, understanding the withdrawal risks of antiseizure drugs is essential for healthcare providers managing patients with seizure disorders. It emphasizes the importance of gradual tapering of these medications to prevent rebound seizures and withdrawal symptoms. In the context of patient care, this knowledge can help in making informed decisions regarding drug therapy adjustments to ensure the safety and well-being of individuals with seizure disorders.
Ethosuximide is the least likely to increase seizure frequency upon withdrawal compared to the other options. This is because ethosuximide is primarily used in absence seizures and does not have significant effects on other types of seizures. Therefore, its withdrawal is less likely to lead to rebound seizures.
Clonazepam (Option A) and Diazepam (Option B) are benzodiazepines commonly used for seizure control. Abrupt withdrawal of these drugs can lead to rebound seizures due to their potent antiseizure effects and potential for dependence.
Phenobarbital (Option D) is a barbiturate with a long half-life and potent antiseizure properties. Abrupt discontinuation of phenobarbital can result in a withdrawal syndrome characterized by an increased risk of seizures.
Educationally, understanding the withdrawal risks of antiseizure drugs is essential for healthcare providers managing patients with seizure disorders. It emphasizes the importance of gradual tapering of these medications to prevent rebound seizures and withdrawal symptoms. In the context of patient care, this knowledge can help in making informed decisions regarding drug therapy adjustments to ensure the safety and well-being of individuals with seizure disorders.